Human Papillomavirus Testing in Head and Neck Squamous Cell Carcinoma: Best Practice for Diagnosis
- 18 June 2014
- book chapter
- Published by Springer Nature
- Vol. 1180, 237-255
Abstract
Human papillomavirus (HPV)-associated oropharyngeal carcinoma is now recognized as a clinically distinct subtype of head and neck cancer with important prognostic implications. HPV testing is recommended as the standard of care for all patients diagnosed with oropharyngeal squamous cell carcinoma. Here, we describe a practical approach to HPV testing within the setting of the diagnostic histopathology laboratory.Keywords
This publication has 51 references indexed in Scilit:
- Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United StatesJournal of Clinical Oncology, 2011
- Trends in the incidence rates of tonsil and base of tongue cancer in England, 1985–2006The Annals of The Royal College of Surgeons of England, 2010
- Trends in head and neck cancer incidence in Denmark, 1978–2007: Focus on human papillomavirus associated sitesInternational Journal of Cancer, 2010
- HPV-associated head and neck cancer: a virus-related cancer epidemicThe Lancet Oncology, 2010
- Human Papillomavirus in Head and Neck Cancer: Its Role in Pathogenesis and Clinical ImplicationsClinical Cancer Research, 2009
- Oral and oropharyngeal cancer in The Netherlands between 1989 and 2006: Increasing incidence, but not in young adultsOral Oncology, 2009
- Controversies surrounding human papilloma virus infection, head & neck vs oral cancer, implications for prophylaxis and treatmentHead & Neck Oncology, 2009
- Incidence Trends for Human Papillomavirus–Related and –Unrelated Oral Squamous Cell Carcinomas in the United StatesJournal of Clinical Oncology, 2008
- Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic ReviewCancer Epidemiology, Biomarkers & Prevention, 2005
- HPV infections and tonsillar carcinomaJournal of Clinical Pathology, 2004